Frequently Asked Questions
General Information
Q: Where are King Pharmaceuticals Canada's offices and facilities located?
A: King Pharmaceuticals Canada Inc. is based in Mississauga, Canada, where its administrative and sales/marketing offices, warehousing and distribution are located.
Q: How can I contact King Pharmaceuticals Canada?
A: We can be reached as follows:
King Pharmaceuticals Canada, Inc.
2915 Argentia Road, Suite 7
Mississauga, Ontatio, L5N 8G6
1 (905) 812-9911
info@kingpharm.ca
Corporate Structure
Q: What is King Pharmaceuticals Canada's relationship to King Pharmaceuticals?
A: King Pharmaceuticals Canada is part of King Pharmaceuticals, Inc. a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in cardiovascular/metabolics, neuroscience, and hospital/acute care.
Investor Information
Q: How can I access investor-related information regarding King Pharmaceuticals, Inc.?
A: For more investor-related information on King Pharmaceuticals, please visit the Investor Relations section on the King Pharmaceuticals, Inc. U.S. website.
Business Development
Q: How do I submit a new business proposal?
A: King is committed to improving and protecting the quality of life through an active program of business development. The Company also considers compelling strategic opportunities related to other therapeutic categories which complement our core commercial, R&D and Manufacturing capabilities. If you are interested in presenting a business development opportunity to King, please submit a proposal through our online new business portal. Alternatively, you can send or e-mail your expression of interest in writing to:
King Business Development
King Pharmaceuticals, Inc.
400 Crossing Boulevard
Bridgewater, NJ 08807
Fax: (423) 274-2602
Products
Q: Which King Pharmaceuticals products are marketed in Canada?
A: King Pharmaceuticals Canada sells and markets Cytomel® and also holds the exclusive license for sales and marketing of EpiPen® in Canada.
Cytomel is a registered trade mark of King Pharmaceuticals Research and Development, Inc. a wholly owned subsidiary of King Pharmaceuticals, Inc.
EpiPen® and EpiPen® Jr are registered trademarks of Mylan Inc. licensed exclusively to its wholly-owned subsidiary, Dey Pharma, L.P. of Basking Ridge, New Jersey, USA.